RHTNK-TPA

Clinical trials for RHTNK-TPA explained in plain language.

Never miss a new study

Get alerted when new RHTNK-TPA trials appear

Sign up with your email to follow new studies for RHTNK-TPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New stroke drug safety check: which clot buster is safer?

Disease control Not yet recruiting

This study looks at the safety of two medicines that dissolve blood clots in the brain during a stroke. About 4,500 adults who have had a stroke will receive either the newer drug rhTNK-tPA or the standard drug rt-PA. Researchers will track how many people have serious bleeding i…

Matched conditions: RHTNK-TPA

Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. • Aim: Disease control

Last updated May 18, 2026 12:13 UTC

RHTNK-TPA

Get alerted when new RHTNK-TPA trials appear

New stroke drug safety check: which clot buster is safer?